cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?

• Nicola Normanno,
• Antonella De Luca,
• Francesco Perrone

Affiliations

Nicola Normanno

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy; Corresponding author.

Antonella De Luca

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy

Francesco Perrone

Clinical Trials Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy